US4560678A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Novel therapeutic composition useful particularly for healing wounds
Assignee: Individual
•
Filing: 1983-11-07
•
Granted: 1985-12-24
•
Expires: 2003-11-07
Abstract
Abstract A therapeutic composition containing allantoin and desoxyribonycleic acid is useful for the healing of wounds.
Inventors
- 👤 Michele Ranson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 08:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
38 words
A therapeutic composition useful for the treatment of wounds, constituted by an association of an amount effective to improve healing of wounds of each of allantoin and highly polymerized desoxyribonuncleic acid (DNA) and optionally a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
38 words
A therapeutic composition useful for the treatment of wounds, constituted by an association of an amount effective to improve healing of wounds of each of allantoin and highly polymerized desoxyribonuncleic acid (DNA) and optionally a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
17 words
Composition according to claim 1, wherein the ratio by weight allantoin/DNA is comprissed between 1/2 to 1/8.
Claim 4
Dependent Claim
21 words
Composition according to claim 2, comprising in addition 5,000 to 20,000 I.U. of vitamin A per 1 g of said composition.
Claim 5
Dependent Claim
13 words
Composition according to claim 3, containing 2 to 100% (weight/weight) of active principles.
Claim 6
Dependent Claim
13 words
Composition according to claim 2, containing 2 to 100% (weight/weight) of active principles.
Claim 7
Dependent Claim
21 words
Composition according to claim 1, comprising in addition 5,000 to 20,000 I.U. of vitamin A per 1 g of said composition.
Claim 8
Dependent Claim
13 words
Composition according to claim 6, containing 2 to 100% (weight/weight) of active principles.
Claim 9
Dependent Claim
13 words
Composition according to claim 1, containing 2 to 100% (weight/weight) of active principles.
Claim 10
Dependent Claim
19 words
Composition according to claim 1 wherein said pharmaceutically acceptable carrier is water, and said composition is in gel form.
Claim 11
Dependent Claim
17 words
Composition according to claim 9, wherein the ratio by weight allantoin/DNA is comprised between 1/2 and 1/8.
Claim 12
Dependent Claim
23 words
Composition according to claim 10, comprising in addition 5 000 to 20 000 I.U. of vitamin A per 1 g of said composition.
Claim 13
Dependent Claim
23 words
Composition according to claim 9, comprising in addition 5 000 to 20 000 I.U. of vitamin A per 1 g of said composition.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-12-23 | 1989-06-24 | 1989-12-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-12-23 | 1993-06-24 | 1993-12-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-12-23 | 1997-06-24 | 1997-12-24 | $7700.00 | Window Closed / Lapsed |